Clinical Trial Update: Post-treatment Surveillance in HPV+ Oropharyngeal SCC

View source ↗

Summary

Clinical trial NCT04965792 at Dana-Farber Cancer Institute is currently active but not recruiting, focusing on post-treatment surveillance in HPV-positive oroph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection
• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: HPV, Oropharyngeal Squamous Cell Carcinoma | Status: ACTIVE_NOT_RECRUITING